Clinical trial
Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic…
NCT00125437 · Hebei Medical University, Other · Terminated
Key facts
| NCT number | NCT00125437 |
|---|---|
| Title | Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy |
| Official title | Safety and Efficacy of Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy |
| Lead sponsor | Hebei Medical University, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive |
| Intervention type | Drug |
| Interventions | spironolactone |
| Enrollment | 200 |
| Start date | Sep 1, 2005 |
| Completion | Sep 1, 2009 |
| First posted | Aug 1, 2005 |
| Last update posted | Jul 15, 2009 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: